BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26232753)

  • 1. Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer.
    Rehbein G; Schmidt B; Fleischhacker M
    Clin Chim Acta; 2015 Oct; 450():78-82. PubMed ID: 26232753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.
    Schmidt B; Rehbein G; Fleischhacker M
    Adv Exp Med Biol; 2016; 924():33-37. PubMed ID: 27753015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.
    Charkiewicz R; Pilz L; Sulewska A; Kozlowski M; Niklinska W; Moniuszko M; Reszec J; Manegold C; Niklinski J
    Int J Cancer; 2016 Feb; 138(3):689-97. PubMed ID: 26311306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
    Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
    World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
    Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
    Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
    Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
    Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
    Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.
    Rapa I; Votta A; Felice B; Righi L; Giorcelli J; Scarpa A; Speel EJ; Scagliotti GV; Papotti M; Volante M
    Neuroendocrinology; 2015; 101(3):246-55. PubMed ID: 25791280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
    Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
    Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
    Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
    Jiang L; Huang Q; Chang J; Wang E; Qiu X
    Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
    Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression differentiates between primary lung tumors and metastases to the lung.
    Barshack I; Lithwick-Yanai G; Afek A; Rosenblatt K; Tabibian-Keissar H; Zepeniuk M; Cohen L; Dan H; Zion O; Strenov Y; Polak-Charcon S; Perelman M
    Pathol Res Pract; 2010 Aug; 206(8):578-84. PubMed ID: 20418022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.